Abliva Ab (NEVPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,105 | -8,244 | -14,398 | -6,548 | -8,154 |
| Depreciation Amortization | 173 | 259 | 310 | 279 | 252 |
| Other Working Capital | 7,180 | -7,967 | 729 | -1,103 | 234 |
| Other Operating Activity | 1,016 | 140 | 58 | 8 | 8 |
| Operating Cash Flow | $-736 | $-15,812 | $-13,301 | $-7,364 | $-7,661 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -122 | -2 | -8 | N/A | -7 |
| Purchase Sale Intangibles | N/A | -87 | -119 | -153 | -278 |
| Other Investing Activity | 0 | -87 | -119 | -153 | -278 |
| Investing Cash Flow | $-122 | $-90 | $-127 | $-153 | $-285 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 71 | 17,874 | 8,846 | 7,910 | 11,403 |
| Other Financing Activity | -32 | 2,384 | -9 | -29 | -33 |
| Financing Cash Flow | $39 | $20,258 | $8,837 | $7,880 | $11,370 |
| Exchange Rate Effect | -5 | 10 | 8 | -1 | 0 |
| Beginning Cash Position | 6,261 | 2,214 | 7,188 | 6,357 | 2,746 |
| End Cash Position | 5,438 | 6,579 | 2,605 | 6,719 | 6,170 |
| Net Cash Flow | $-823 | $4,366 | $-4,583 | $362 | $3,425 |
| Free Cash Flow | |||||
| Operating Cash Flow | -736 | -15,812 | -13,301 | -7,364 | -7,661 |
| Capital Expenditure | -122 | -2 | -8 | N/A | -7 |
| Free Cash Flow | -857 | -15,815 | -13,309 | -7,364 | -7,669 |